Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol

BMC Pediatrics

Jane M Alsweiler³  Greg Gamble¹  Richard Edlin¹  Caroline A Crowther¹  Joanne E Hegarty²  Jane E Harding¹ 

[1] Liggins Institute, University of Auckland, Auckland, New Zealand;Newborn Services, Auckland City Hospital, Auckland, New Zealand;Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand

关键词: Randomised controlled trial;    Neonate;    Oral dextrose gel;    Hypoglycaemia;   

Others  :  1225227
DOI  :  10.1186/s12887-015-0440-6

 received in 2015-02-08, accepted in 2015-09-01,  发布年份 2015

【 摘 要 】

Background

Neonatal hypoglycaemia is common, affecting up to 15 % of newborn babies and 50 % of those with risk factors (preterm, infant of a diabetic, high or low birthweight). Hypoglycaemia can cause brain damage and death, and babies born at risk have an increased risk of developmental delay in later life.

Treatment of hypoglycaemia usually involves additional feeding, often with infant formula, and admission to Neonatal Intensive Care for intravenous dextrose. This can be costly and inhibit the establishment of breast feeding.

Prevention of neonatal hypoglycaemia would be desirable, but there are currently no strategies, beyond early feeding, for prevention of neonatal hypoglycaemia. Buccal dextrose gel is safe and effective in treatment of hypoglycaemia. The aim of this trial is to determine whether 40 % dextrose gel given to babies at risk prevents neonatal hypoglycaemia and hence reduces admission to Neonatal Intensive Care.

Methods/design

Design: Randomised, multicentre, placebo controlled trial.

Inclusion criteria: Babies at risk of hypoglycaemia (preterm, infant of a diabetic, small or large), less than 1 h old, with no apparent indication for Neonatal Intensive Care Unit admission and mother intends to breastfeed.

Trial entry & randomisation: Eligible babies of consenting parents will be allocated by online randomisation to the dextrose gel group or placebo group, using a study number and corresponding trial intervention pack.

Study groups: Babies will receive a single dose of 0.5 ml/kg study gel at 1 h after birth; either 40 % dextrose gel (200 mg/kg) or 2 % hydroxymethylcellulose placebo. Gel will be massaged into the buccal mucosal and followed by a breast feed.

Primary study outcome: Admission to Neonatal Intensive Care.

Sample size: 2,129 babies are required to detect a decrease in admission to Neonatal Intensive Care from 10–6 % (two-sided alpha 0.05, 90 % power, 5 % drop-out rate).

Discussion

This study will investigate whether admission to Neonatal Intensive Care can be prevented by prophylactic oral dextrose gel; a simple, cheap and painless intervention that requires no special expertise or equipment and hence is applicable in almost any birth setting.

Trial registration

Australian New Zealand Clinical Trials Registry - ACTRN 12614001263684.

【 授权许可】

   
2015 Harding et al.

【 参考文献 】

• [1]Hay WWJ, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009; 155(5):612-7.
• [2]Maayan-Metzger A, Lubin D, Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology. 2009; 96(2):80-5.
• [3]Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012; 161(5):787-91.
• [4]Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 1988; 297(6659):1304-8.
• [5]Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008; 122(1):65-74.
• [6]Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr. 1999; 134(4):492-8.
• [7]Leitner Y, Fattal-Valevski A, Geva R, Eshel R, Toledano-Alhadef H, Rotstein M et al.. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol. 2007; 22(5):580-587.
• [8]Silverman BL, Rizzo T, Green OC, Cho NH, Winter RJ, Ogata ES et al.. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991; 40 Suppl 2:121-125.
• [9]Stenninger E, Flink R, Eriksson B, Sahlen C. Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy. Arch Dis Child Fetal Neonatal Ed. 1998; 79(3):F174-9.
• [10]Woythaler MA, McCormick MC, Smith VC. Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants. Pediatrics. 2011; 127(3):e622-9.
• [11]Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, Reijneveld SA, Bos AF. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics. 2012; 130(2):e265-72.
• [12]Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011; 127(3):575-9.
• [13]Canadian Pediatric Society Fetal and Newborn Committee: Screening guidelines for newborns at risk for low blood glucose. Paediatr Child Health. 2004;9(10):723–40.
• [14]Cornblath M, Ichord R. Hypoglycemia in the neonate. Semin Perinatol. 2000; 24(2):136-49.
• [15]Koh TH, Aynsley-Green A, Tarbit M, Eyre JA. Neural dysfunction during hypoglycaemia. Arch Dis Child. 1988; 63(11):1353-8.
• [16]Rozance PJ, Hay WWJ. Hypoglycemia in newborn infants: Features associated with adverse outcomes. Biol Neonate. 2006; 90(2):74-86.
• [17]Harris DL, Weston PJ, Battin MR, Harding JE. A survey of the management of neonatal hypoglycaemia within the Australian and New Zealand Neonatal Network. J Paediatr Child Health. 2009; 50(10):E55-62.
• [18]Blomquist HK, Jonsbo F, Serenius F, Persson LA. Supplementary feeding in the maternity ward shortens the duration of breast feeding. Acta Paediatr. 1994; 83(11):1122-6.
• [19]Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet. 2001; 357(9254):413-9.
• [20]Singhal A, Farooqi IS, O’Rahilly S, Cole TJ, Fewtrell M, Lucas A. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002; 75(6):993-9.
• [21]Harris DL, Weston PJ, Signal M, Chase JG, Harding JE. Dextrose gel for treating neonatal hypoglycaemia: A randomised placebo-controlled trial (The Sugar Babies Study). Lancet. 2013; 382(9910):2077-2083.
• [22]Australian and New Zealand Neonatal Network: ANZNN DATA DICTIONARY: Australia: National Perinatal Epidemiology and Statistics Unit (NPESU); 2014; p. 90.